![]() |
市場調查報告書
商品編碼
1776765
2032 年培養肉市場預測:按產品類型、產地、細胞、生產技術、分銷管道、最終用戶和地區進行的全球分析Lab-grown Meat Market Forecasts to 2032 - Global Analysis By Product Type, Source, Cell, Production Technique, Distribution Channel, End User and By Geography |
根據 Stratistics MRC 的數據,全球培養肉市場預計在 2025 年達到 2.5 億美元,到 2032 年將達到 10.3 億美元,預測期內的複合年成長率為 22.3%。
實驗室培養肉,也稱為培養肉或細胞肉,是在受控的實驗室環境中培養動物細胞而產生的,無需飼養或屠宰牲畜。這個過程包括從動物體內提取幹細胞,並在營養豐富的生物反應器中培養,形成模擬傳統肉類的肌肉組織。這種方法旨在減少對環境的影響,提高食品安全,並解決與傳統畜牧業相關的倫理問題。培養肉可支持永續的蛋白質生產,並提供可擴展的清潔標籤應用。
據 CE Delft(透過 Good Food Institute)稱,與傳統牛肉相比,利用可再生能源生產的培養肉可減少高達 92% 的溫室氣體排放、減少 95% 的土地使用量和減少 78% 的水使用量。
糧食資源壓力加大,蛋白質需求上升
全球人口成長和都市化對傳統食品體系,尤其是畜牧業生產帶來越來越大的壓力。由於傳統肉類生產難以滿足日益成長的蛋白質需求,實驗室培育肉類正逐漸成為一種可行的替代方案,它提供了一種可擴展的解決方案,避免了土地密集型農業,並減少了對畜牧業生產的依賴。此外,培養肉還能滿足消費者對符合道德規範且永續的蛋白質來源不斷變化的偏好。該技術還透過在受控環境中實現局部生產來支持糧食安全目標。
監管障礙和缺乏清晰的框架
缺乏標準化的核准途徑會延遲商業化進程,並為投資者和生產商帶來不確定性。此外,細胞肉類的標籤法規和安全通訊協定仍有爭議,使得市場准入更加複雜。消費者教育的匱乏以及對合成食品技術的質疑加劇了這些挑戰。在製定明確的指導方針之前,合規風險和緩慢的普及可能會限制其發展。
肉類產品的多樣化和優質化
實驗室培育肉類為超越傳統肉塊的新產品形態打開了大門,包括混合肉、美食應用和客製化營養成分。這種靈活性使生產者能夠滿足利基市場的需求,例如高級餐廳、注重健康的消費者以及特定文化的飲食習慣。優質化也推動了人們對培養肉類作為奢侈品或特色產品的興趣,尤其是在城市中心地區。隨著生產成本的下降,企業可以擴大產品範圍,包括水產品仿製品、異國肉類和機能性食品。
意外的健康或環境影響
雖然實驗室培育肉類被定位為永續的替代品,但其長期健康和生態影響仍在研究中。潛在風險包括細胞培養過程中的污染、意外的基因突變以及對資源密集型生長培養基的依賴。此外,如果不進行最佳化,大規模生物反應器操作可能會帶來新的環境負擔。如果出現不利的發現,公眾的看法可能會發生負面轉變,導致監管方面的強烈反對,並削弱消費者的信任。
疫情暴露了全球肉類供應鏈的脆弱性,加速了人們對培養肉的興趣。屠宰場的停工以及對通用感染疾病日益成長的擔憂,促使消費者尋求更安全、實驗室控制的替代品。同時,肉類科技投資激增,新興企業獲得資金以擴大其細胞培養肉類解決方案的規模。整體而言,新冠疫情成為創新的催化劑,並凸顯了細胞培養肉類系統在危機情況下的韌性。
漢堡和肉餅市場預計將成為預測期內最大的市場
漢堡和肉餅市場預計將在預測期內佔據最大市場佔有率,這得益於其為人所知且易於融入現有食品服務菜單的特點。與整塊肉相比,這些產品的結構複雜度要求較低,因此非常適合早期商業化。它們在快餐連鎖店和快餐店的受歡迎程度進一步推動了需求。此外,消費者在漢堡等熟悉的食品形式下嘗試替代蛋白質的意願也不斷增強,這加速了市場滲透。
預計預測期內,基於鷹架的技術產業將實現最高複合年成長率
預計基於支架的技術領域將在預測期內實現最高成長率,因為它能夠複製傳統肉類的質地和結構。該技術使用可食用或生物分解性的框架來引導細胞生長,從而能夠生產牛排和魚片等整塊肉。生物材料和3D列印技術的進步使其更具擴充性和成本效益。隨著消費者對更逼真的口味和質地的期望不斷提升,基於支架的方法正受到製造商和投資者的青睞。
在預測期內,亞太地區預計將佔據最大的市場佔有率,這得益於肉類消費的成長、快速的都市化以及政府的支持性政策。新加坡、日本和中國等國家在培養肉類的監管核准和基礎建設方面處於主導地位。該地區對食品創新的開放態度,加上對食品安全和永續性日益成長的關注,使其成為培養肉類應用的沃土。戰略夥伴關係和公私舉措正在進一步加速整個亞太地區的商業化進程。
在預測期內,北美預計將呈現最高的複合年成長率,這得益於強勁的投資活動、先進的生物技術生態系統以及消費者意識的不斷提升。尤其是美國,專注於細胞農業的新興企業和創業投資正在激增。監管機構正在積極與行業相關人員溝通,以製定清晰的核准路徑。此外,該地區對道德消費和氣候意識選擇的重視,正在推動零售和餐飲通路對實驗室培育肉類的需求。
According to Stratistics MRC, the Global Lab-grown Meat Market is accounted for $0.25 billion in 2025 and is expected to reach $1.03 billion by 2032 growing at a CAGR of 22.3% during the forecast period. Lab-grown meat, also known as cultivated or cell-based meat, is produced by culturing animal cells in a controlled laboratory environment without raising or slaughtering livestock. The process involves extracting stem cells from animals and growing them in nutrient-rich bioreactors to form muscle tissue that replicates conventional meat. This approach aims to reduce environmental impact, improve food security, and address ethical concerns linked to traditional animal farming. Lab-grown meat supports sustainable protein production with potential for scalable, clean-label applications.
According to CE Delft (via Good Food Institute), lab grown meat produced using renewable energy can emit up to 92% less greenhouse gases, use 95% less land, and 78% less water compared to conventional beef.
Increasing pressure on food resources and a rising demand for protein
Global population growth and urbanization are intensifying the strain on traditional food systems, especially livestock farming. As conventional meat production struggles to meet escalating protein needs, lab-grown meat emerges as a viable alternative. It offers a scalable solution that bypasses land-intensive agriculture and reduces dependence on animal husbandry. Moreover, cultivated meat aligns with shifting consumer preferences for ethical and sustainable protein sources. The technology also supports food security goals by enabling localized production in controlled environments.
Regulatory hurdles and lack of clear frameworks
The absence of standardized approval pathways delays commercialization and creates uncertainty for investors and producers. Additionally, labeling conventions and safety protocols for cell-based meat remain under debate, complicating market entry. These challenges are compounded by limited consumer education and skepticism around synthetic food technologies. Until clear guidelines are established, growth may be constrained by compliance risks and slow adoption.
Diversification of meat products and premiumization
Lab-grown meat opens doors to novel product formats beyond traditional cuts, including hybrid blends, gourmet applications, and customized nutrition profiles. This flexibility allows producers to cater to niche markets such as high-end restaurants, health-conscious consumers, and culturally specific diets. Premiumization is also driving interest in cultivated meat as a luxury or specialty item, especially in urban centers. As production costs decline, companies can expand offerings to include seafood analogs, exotic meats, and functional food variants.
Unforeseen health or environmental impacts
While lab-grown meat is positioned as a sustainable alternative, long-term health and ecological effects are still under investigation. Potential risks include contamination during cell culture, unintended genetic mutations, or reliance on resource-intensive growth media. Additionally, large-scale bioreactor operations may introduce new environmental burdens if not optimized. Public perception could shift negatively if adverse findings emerge, leading to regulatory backlash or reduced consumer trust.
The pandemic accelerated interest in lab-grown meat by exposing vulnerabilities in global meat supply chains. Disruptions in slaughterhouses and rising concerns over zoonotic diseases prompted consumers to seek safer, lab-controlled alternatives. At the same time, investment in food tech surged, with startups receiving increased funding to scale cultivated meat solutions. Overall, COVID-19 acted as a catalyst for innovation and highlighted the resilience of cell-based meat systems in crisis scenarios.
The burgers & patties segment is expected to be the largest during the forecast period
The burgers & patties segment is expected to account for the largest market share during the forecast period due to their familiarity and ease of integration into existing foodservice menus. These formats require less structural complexity compared to whole cuts, making them ideal for early-stage commercialization. Their popularity among fast-food chains and quick-service restaurants further boosts demand. Additionally, consumer willingness to try alternative proteins is higher when presented in familiar formats like burgers, accelerating market penetration.
The scaffold-based technique segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the scaffold-based technique segment is predicted to witness the highest growth rate owing to its ability to replicate the texture and structure of conventional meat. This technique uses edible or biodegradable frameworks to guide cell growth, enabling the production of whole cuts such as steaks and fillets. Advances in biomaterials and 3D printing are enhancing scalability and cost-efficiency. As consumer expectations shift toward realism in taste and texture, scaffold-based methods are gaining traction among manufacturers and investors.
During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by rising meat consumption, rapid urbanization, and supportive government policies. Countries like Singapore, Japan, and China are leading in regulatory approvals and infrastructure development for cultivated meat. The region's openness to food innovation, coupled with growing concerns over food safety and sustainability, makes it a fertile ground for adoption. Strategic partnerships and public-private initiatives are further accelerating commercialization across APAC.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by strong investment activity, advanced biotech ecosystems, and increasing consumer awareness. The U.S. in particular has seen a surge in startups and venture capital focused on cellular agriculture. Regulatory agencies are actively engaging with industry stakeholders to establish clear pathways for approval. Additionally, the region's emphasis on ethical consumption and climate-conscious choices is driving demand for lab-grown meat across retail and foodservice channels.
Key players in the market
Some of the key players in Lab-grown Meat Market include Mosa Meat, Upside Foods, Orbillion Bio, Shiok Meats, New Age Meats, BioCraft Pet Nutrition, SuperMeat, BlueNalu, Avant Meats, Mission Barns, Gourmey, CellX, Higher Steaks and Peace of Meat
In April 2025, BlueNalu expanded its partnership with Nomad Foods (Birds Eye) to support UK regulatory and commercial rollout of cell-cultivated seafood. The move aligns with ongoing efforts to enter the UK market and meet early consumer demand.
In March 2025, Mission Barns secured FDA clearance ("No Questions" letter) for its cultivated pork fat, becoming the first company globally with such approval. The company plans a U.S. launch via partnerships with Fiorella restaurants and Sprouts Farmers Market.
In February 2025, SuperMeat announced collaboration with biotech firm Stamm to integrate continuous bioprocessing into its cultivated chicken production. Supported by shared investor Varana Capital, the partnership aims to enhance process yields and scalability.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.